Oura Pays $625 Million in Cash for AI Doctor Startup Counsel Health, Turning a Smart Ring Into a Front Door for Primary Care

Oura is buying AI-native primary care company Counsel Health for $625 million in cash, aiming to move its 6 million-plus members from sleep and heart-rate insights to physician care inside the Oura app, weeks after shelving its IPO.

Read more

FDA Approves Bayer’s Sunharbo, the First Factor XIa Blood Thinner, Cutting Repeat Strokes 26% as a $748 Monthly Price Tests Demand

The FDA cleared Bayer’s Sunharbo (asundexian), the first Factor XIa inhibitor, after a 12,327-patient trial showed a 26% drop in repeat ischemic strokes without more major bleeding. Here is what the approval means for Bayer, its rivals and payers.

Read more